Elbasvir/Grazoprevir Experience- A New Glance at HCV Treatment: Case Report

Hepatitis C is a viral disease having a worldwide importance and posing a risk for liver complications. With the new treatment options, it is easy to manage with higher rates of success. Among them, one of the most recent one is elbasvir/grazoprevir option. This study presents the results of two tre...

Full description

Saved in:
Bibliographic Details
Published inViral Hepatit Dergisi Vol. 23; no. 1; pp. 34 - 36
Main Authors ÇELEN, Mustafa Kemal, AKDEMİR, İrem, TEKİN, Recep, BAYAN, Kadim, AYAZ, Celal
Format Journal Article
LanguageEnglish
Published Ankara Viral Hepatitle Savaşım Derneği 01.04.2017
Galenos Publishing House
Subjects
Case reports
Drug dosages
Genotype & phenotype
Hepatitis
Infections
Interferon
Liver cancer
Liver cirrhosis
Patients
Tıp
Ankara
Hepatit C virüs
Hepatitis C virus
oral antiviral treatment
elbasvir/grazoprevir
oral antiviral tedavi
Online AccessGet full text

Cover

More Information
Summary:Hepatitis C is a viral disease having a worldwide importance and posing a risk for liver complications. With the new treatment options, it is easy to manage with higher rates of success. Among them, one of the most recent one is elbasvir/grazoprevir option. This study presents the results of two treatment-naive patients treated with elbasvir/grazoprevir. The first case was a male non-cirrhotic patient and the second one was a female who suffered from compensated hepatic cirrhosis. Both patients received elbasvir/grazoprevir 50/100 mg in a single tablet for 12 weeks. Persistent viral response was achieved in both patients and no side effect was observed during the treatment. Elbasvir/grazoprevir combination, one of the recent treatments, was considered effective and tolerable.
ISSN:1307-9441
2147-2939
DOI:10.4274/vhd.10337